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3Summary31
The expansion of microbial substrate and product scopes will be an important brick promoting32
future bioeconomy. In this study, an orthogonal pathway running in parallel to native33
metabolism and converting renewable dodecanoic acid methyl ester (DAME) via terminal34
alcohol and aldehyde to 12-aminododecanoic acid methyl ester (ADAME), a building block for35
the high-performance polymer Nylon 12, was engineered in Escherichia coli and optimized36
regarding substrate uptake, substrate requirements, host strain choice, flux, and product yield.37
Efficient DAME uptake was achieved by means of the hydrophobic outer membrane porin38
AlkL increasing maximum oxygenation and transamination activities 8.3 and 7.6-fold,39
respectively. An optimized coupling to the pyruvate node via a heterologous alanine40
dehydrogenase enabled efficient intracellular L-alanine supply, a prerequisite for self-sufficient41
whole-cell transaminase catalysis. Finally, the introduction of a respiratory chain-linked alcohol42
dehydrogenase enabled an increase in pathway flux, the minimization of undesired43
overoxidation to the respective carboxylic acid, and thus the efficient formation of ADAME as44
main product. The completely synthetic orthogonal pathway presented in this study sets the45
stage for Nylon 12 production from renewables. Its effective operation achieved via fine tuning46
the connectivity to native cell functionalities emphasizes the potential of this concept to expand47
microbial substrate and product scopes.48
49
Keywords: orthogonal pathway engineering, in vivo cascade biocatalysis, substrate uptake,50
Nylon 12, renewable plastics.51
Chemical compounds studied in this article:52
Methyl dodecanoate (PubChem CID: 8139); Methyl 12-hydroxydodecanoate (PubChem CID:53
522424); Dodecanedioic acid monomethyl ester (PubChem CID: 231998); Methyl 12-54
aminododecanoate (PubChem CID: 3665980)55
41. Introduction56
Synthetic polyamides offer excellent chemical and physical properties for various applications57
as packing materials and parts in the automotive, construction, and medical industries (Carole58
et al., 2004; Schmitz and Schepers, 2004). Important representatives of the group of aliphatic59
polyamides are Nylon 6, 6.6, 6.12, 11, and 12 (Palmer, 2001). Nylon 12 constitutes a high60
performance polymer featuring extraordinary heat, abrasion, chemical, UV, and scratch61
resistance (Evonik Industries, 2015). Typically, Nylon 12 is produced from the monomer ω-62
laurolactam, of which the chemical synthesis is initiated by the trimerization of 1,3-butadiene63
originating from steam cracking of crude oil (Dachs and Schwartz, 1962; Franke and Müller,64
1964). However, at times of decreasing crude oil resources, increasing concerns about process65
safety, and rising negative economic and environmental implications of crude oil use, the66
substitution of petrochemical with bio-based synthesis routes becomes more and more67
interesting.68
Approaches involving the biotechnological production of polymer building blocks for, e.g.,69
Nylons (Curran et al., 2013; Kind et al., 2014; Niu et al., 2002) or polyesters (Lee et al., 2005)70
synthesis, typically are based on renewable resources and make use of microbes as production71
organisms. Systems biotechnology and metabolic engineering thereby facilitated the design of72
such whole-cell catalysts and enabled productivity and yield enhancements via the genetic73
modification of native microbial pathways and their regulation.74
The design and construction of non-natural, heterologous and in this sense orthogonal pathways75
consisting of enzymes originating from different pathways/strains and running as separate76
synthetic modules in parallel to native metabolism (Oberleitner et al., 2013; Schrewe et al.,77
2013b; Song et al., 2013) can be considered a novel metabolic engineering approach to enlarge78
the substrate and product scope of microbial bioprocesses. However, the hitherto poor79
performance of such pathways and their coupling to the microbial physiology represent major80
5challenges, which remain to be tackled. Recently, we combined oxygenase and transaminase81
catalysis in such an orthogonal pathway for the conversion of plant oil derived dodecanoic acid82
methyl ester (DAME) to 12-aminododecanoic acid methyl ester (ADAME), a monomer83
suitable for Nylon 12 synthesis (Schrewe et al., 2013b). ADAME was produced in E. coli via a84
three-step cascade, in which terminal DAME hydroxylation and alcohol oxidation both85
catalyzed by the alkane monooxygenase AlkBGT from Pseudomonas putida GPo1 were86
followed by terminal amination by means of the Chromobacterium violaceum -transaminase87
(CV2025) (Fig. 1). Thereby, dodecanedioic acid monomethyl ester (DDAME) was formed as88
a major by-product.89
90
Fig. 1: Terminal oxy- and aminofunctionalization of DAME. AlkBGT, alkane monooxygenase;91
ω-TA, -transaminase CV2025; DAME, dodecanoic acid methyl ester; HDAME, 12-92
hydroxydodecanoic acid methyl ester; ODAME, 12-oxododecanoic acid methyl ester;93
DDAME, dodecanedioic acid monomethyl ester; ADAME, 12-aminododecanoic acid methyl94
ester; R, COOCH3.95
96
Limited substrate uptake into the cells, the necessity to feed L-alanine as cosubstrate for the97
transamination reaction, and by-product formation have been identified as critical factors. This98
study reports the redesign of the whole-cell catalyst for the efficient conversion of DAME to99
ADAME via orthogonal pathway and metabolic engineering. Approaches include the100
introduction of the outer membrane protein AlkL, which has been shown to enhance101
6hydrophobic substrate uptake over the outer membrane of recombinant E. coli (Cornelissen et102
al., 2013; Julsing et al., 2012), L-alanine supply via a heterologous alanine dehydrogenase103
making use of intracellular alanine and pyruvate pools, and the increase of the flux through the104
orthogonal pathway via the introduction of a heterologous alcohol dehydrogenase catalyzing105
irreversible alcohol oxidation. Furthermore, different E. coli host strains were evaluated106
regarding their ability to cope with the non-natural substrates and intermediates and their107
potential to efficiently synthesize the Nylon 12 monomer ADAME from renewables.108
109
2. Materials and Methods110
2.1 Chemicals111
DAME (99.8%), 12-hydroxydodecanoic acid methyl ester (HDAME; ≥95%), 12-112
oxododecanoic acid methyl ester (ODAME; ≥95%), ADAME (99.3%), and 12-113
aminododecanoic acid (96%) were obtained from Evonik Degussa GmbH (Marl, Germany).114
All other chemicals used in this work were obtained from Carl Roth GmbH + Co KG115
(Karlsruhe, Germany), Merck KGaA (Darmstadt, Germany), Sigma Aldrich (Steinheim,116
Germany), and TCI Europe (Zwijndrecht, Belgium) in the highest purity available.117
2.2 Strains, plasmids, and cultivation118
Strains and plasmids used in this work are listed in Table 1. E. coli DH5 was used for cloning119
purposes and E. coli JM101, E. coli W3110, and E. coli BL21 (DE3) for biotransformation120
studies. Recombinant strains were obtained by introduction of plasmid DNA into the host121
strains via electroporation (2.5 kV, EquiBio Easyjet Pima Ashford UK). Transformants were122
selected via their antibiotic resistance.123
Cultivations were carried out at 37 °C in LB medium (Sambrook, 2001) and at 30 °C for cultures124
in M9* minimal medium (Panke et al., 1999) supplemented with USFe trace element solution125
(Bühler et al., 2003) and 0.5% (w/v) glucose. For cultivation, a Multitron orbital shaker (Infors126
7HT, Bottmingen, Switzerland) was used at 200 rpm. Where appropriate, antibiotics were added:127
50 µg mL−1 kanamycin (Km) and/or 34 µg mL−1 chloramphenicol (Cam). Solid media128
contained 1.5% (w/v) agar. Stock cultures were prepared by addition of 200 µL 50% (v/v)129
glycerol to 800 µL over-night grown LB cultures and stored at −80 °C. 130
131
Table 1: E. coli strains and plasmids132
Characterization References
E. coli strains
BL21 (DE3) F-, ompT, hsdSB (rB− mB−), (DE3 [lacI
lacUV5 T7 gene 1 Sam7 nin5])
(Studier and Moffatt, 1986)
DH5 F-, endA1, glnV44, thi−1, recA1, relA1,
gyrA96, deoR, supE44, 80dlacZM15
(lacZYA−argF)-U169, hsdR15 (rK−
mK+), −
(Hanahan, 1983)
JM101 supE, thi (lac−proAB) F’ [traD36
proAB+ lacIq lacZ M15]
(Messing, 1979)
W3110 F−1 −, rph−1, IN(rrnD−rrnE)1 (Bachmann, 1987)
Plasmids
pTA pACYCDuet−1 derivative, P15A ori, T7-
promoter, carries cv2025 containing a
6xHis-tag and the N-terminal spacer
AGCCAGGATCCGAATTCGAGCTCA,
Camr
(Schrewe et al., 2013b)
pBTL10 derivative of alkane responsive broad-
host-range vector pCom10 (Smits et al.,
2001), colE1 ori, carries alkBFGL and
alkST, Kmr
(Julsing et al., 2012)
pBTLJ10 pCom10 derivative (Smits et al., 2001),
colE1 ori, carries alkBFGJL and alkST,
Kmr
(Schrewe et al., 2014)
pCom10alkL pCom10 derivative (Smits et al., 2001),
carries alkL and alkS, Kmr
(Julsing et al., 2012)
placI P15A ori, carries lacI, Camr Merck KGaA, (Darmstadt,
Germany)
pJ281 P15A ori, lacUV5 promoter, carries alaD
and cv2025 (codon usage changed:
leucine codon changed from ctg to ctc),
Kmr
Evonik Degussa (Marl,
Germany)
pAlaDTA1 placI derivative, lacUV5 promoter, carries
alaD and cv2025, Camr
This study
1 The alaD and cv2025 gene sequences are given in the supplementary material I and II.133
82.3 Construction of pAlaDTA expression vector134
T4 Ligase, thermosensitive Alkaline Phosphatase APTM, and restriction endonucleases were135
purchased from Fermentas GmbH (St. Leon-Rot, Germany) and used according to the136
suppliers’ protocols. All primers were purchased from Eurofins MWG (Ebersberg, Germany).137
Plasmid DNA was isolated using the peqGOLD Miniprep Kit I (PEQLAB Biotechnology138
GmbH, Erlangen, Germany). The alaD-cv2025 operon (including the lacUV5 promoter and139
the rrnB1 terminator) was amplified via PCR from the plasmid pJ281, which was kindly140
provided by Evonik Degussa (Marl, Germany), using the primers 5’-141
GCAGGGCCTGTCTCGGTCGATCATTCAGC-3’ containing an EcoO109I restriction site142
and 5’-CGTAGCCTGAGGCCTGAATATGGCTCATA-3’ containing an Eco81I site. The143
PCR product was cut with EcoO109I/Eco81I, phosphorylated, and ligated into the placI vector144
digested with the same enzymes. Successful cloning yielding the plasmid pAlaDTA was145
verified via sequencing of the insert region (MWG Eurofins, Ebersberg, Germany).146
2.4 Biotransformation procedure147
For precultivation, 5 mL LB medium were inoculated with a single colony from an LB agar148
plate and cultivated for 8 h. 500 µL of the LB culture were used to inoculate 50 mL M9*149
medium, followed by overnight incubation. Subsequently, 100 mL M9* medium were150
inoculated with the M9* preculture to a biomass concentration of 0.03 gCDW L−1. The cells were151
grown to a cell concentration of 0.08 gCDW L−1 and induced with 1 mM isopropyl--152
thiogalactopyranoside (IPTG) (pTA or pAlaDTA containing E. coli strains) and/or with 0.025%153
(v/v) dicyclopropylketone (DCPK) (E. coli strains harboring pCom10alkL, pBTL10, or154
pBTJL10) for 5 h before the cells were harvested and used for whole-cell biotransformations155
which were performed as described before (Schrewe et al., 2013b). The transaminase activity156
was determined in the same way except that the biotransformation buffer (Kpi, 50 mM157
phosphate buffer containing 1% (w/v) glucose, pH 7.4) contained either no supplement, 50 mM158
9L-alanine, or 5 - 15 g L−1 NH4Cl. Activities were calculated in U gCDW−1, where 1 U is defined159
as 1 µmol product formed per min.160
2.5 Analytic procedures161
Analysis of DAME and its oxygenation and transamination products was carried out via gas162
chromatography using a Thermo Scientific UltraTM Chromatograph (Waltham, MA) and163
reversed phase high pressure liquid chromatography using a VWR Hitachi LaChrome Elite164
HPLC system (Darmstadt, Germany) equipped with a Luna C8(2) column (4.6 x 150 mm,165
5 µm, 100Å, Phenomenex, Aschaffenburg, Germany) and connected to a charged aerosol166
Corona detector (ESA Biosciences Inc, Chelmsford, MA) as described before (Schrewe et al.,167
2013b).168
Cell concentrations were determined via measurement of the optical density at 450 nm (OD450)169
(Libra S11 spectrophotometer; Biochrom Ltd., Cambridge, United Kingdom) with an OD450 of170
1 corresponding to 0.166 gCDW L-1 (Blank et al., 2008). SDS-PAGE analysis was performed171
according to the protocol of (Laemmli, 1970).172
173
3. Results174
3.1 AlkL boosts flux through the orthogonal pathway175
Recently, the multistep conversion of renewable DAME to ADAME using whole cells of E.176
coli BL21 (DE3) (pTA, pBT10) was reported (Schrewe et al., 2013b). The poor water solubility177
of DAME and substrate uptake over the cell membrane were discussed as main factors178
restricting production rates (Schrewe et al., 2013b). Julsing et al. (2012) reported that the179
oxygenation activity of recombinant E. coli for hydrophobic hydrocarbons can be drastically180
increased via the introduction of the outer membrane protein AlkL originating from the alkane181
degradation operon of P. putida GPo1. In this study, the outer membrane protein AlkL was182
introduced into recombinant E. coli BL21 (DE3) (pTA) and E. coli BL21 (DE3) (pTA, pBT10)183
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to test its effect on the transamination reaction and the multistep conversion of DAME to184
ADAME, respectively.185
With ODAME as substrate, cells containing AlkL showed 8-times higher specific186
transamination activities as compared to cells without AlkL (Table 2). Specific rates for187
oxygenase-catalyzed DAME and HDAME-oxidation were increased 8.1- and 6.8-fold,188
respectively, considering the full reaction sequence from DAME to ADAME. The189
transamination reaction, with a 7.3-fold increase in specific rate, was significantly favored over190
the competing oxidation of ODAME to DDAME (3.4-fold increase), resulting in the191
accumulation of 0.55 mM ADAME as main product within 60 min (Fig. 2). Hydrolysis of192
HDAME, ADAME, and DDAME to their corresponding acids 12-hydroxydodecanoic acid193
(15% of total alcohol), 12-aminododecanoic acid (2%), and 12-dodecandioic acid (22%) was194
observed during the biotransformation (for details see supplementary material, Fig. S1), as it195
also has been observed before (Schrewe et al., 2013b). As expected, introduction of the outer196
membrane protein AlkL into the whole-cell biocatalyst resulted in increased conversion rates197
for the multistep bioconversion of DAME to ADAME.198
199
Table 2: Effect of AlkL on specific activities of recombinant E. coli BL21 (DE3) for ADAME200
formation from ODAME or DAME.201
Plasmid(s) Substrate Step 1 Step 2 Step 3 Step TA Reference
pTA ODAME −171.91 0.80.11 822.4 (Schrewe et al.,
2013b)
pTA, pBT10 DAME 2.90.2 2.40.1 1.40.1 1.50.1 (Schrewe et al.,
2013b)
pTA,
pCom10alkL
ODAME −320.71 n.d. 62326 This study
pTA,
pBTL10
DAME 23.60.6 16.31.1 4.80.9 11.00.4 This study
Bioconversions were performed under the following conditions: 2.5 mM substrate, 0.5-1.5202
gCDW L−1 of recombinant E. coli BL21 (DE3), and 50 mM L-alanine. Specific activities are203
given in U gCDW−1 (1 U = 1 µmol min-1). The reaction steps are denominated as defined in204
Fig. 1.205
n.d. – not detected.206
1Host intrinsic ODAME reduction and oxidation.207
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Fig. 2: Terminal oxy- and aminofunctionalization of DAME with E. coli BL21 (DE3) (pTA,210
pBTL10). Cell concentration applied: 1.25 gCDW L−1. Kpi buffer was supplemented with 50 mM211
L-alanine. The concentrations of hydrolysis products (i.e., 12-hydroxydodecanoic acid,212
dodecanedioic acid, and 12-aminododecanic acid) were summed up with those of the213
corresponding esters. See supporting information about details on ester hydrolysis.214
Abbreviations are as given in the legend of Fig. 1.215
216
3.2 In vivo supply of the transamination cosubstrate alanine217
L-alanine is a preferred cosubstrate for CV2025 and typically has been used for in vitro218
applications of this transaminase (Kaulmann et al., 2007; Sattler et al., 2012). Native L-alanine219
biosynthesis in E. coli BL21 (DE3) (pTA) was found insufficient to support efficient ODAME220
transamination, for which the ADAME yield on biomass was increased from 0.01 to 0.59221
mmol gCDW−1 when 50 mM L-alanine was provided (Schrewe et al., 2013b). In order to boost222
L-alanine formation from the pyruvate released during transamination or formed during glucose223
catabolism, the alanine dehydrogenase AlaD from B. subtilis was introduced into the microbial224
host strain. This enzyme was chosen, as it has been reported to efficiently support in vitro225
transaminase catalysis via alanine regeneration from pyruvate (Sattler et al., 2012). To evaluate226
“self-sufficient” in vivo transamination, the combination of B. subtilis AlaD and CV2025 was227
tested in different E. coli host strains, i.e., E. coli W3110, E. coli JM101, and E. coli BL21228
(DE3), either with or without AlkL (Table 3). These strains were chosen based on the following229
12
reasons: E. coli W3110 has been shown to be a potent host for AlkBGT-catalysis (Schrewe et230
al., 2011), as it is able to form additional membrane structures upon alkB-overexpression231
(Nieboer et al., 1996); E. coli JM101 has been described as a robust host for various oxygenase-232
catalyzed reactions (Bühler et al., 2000; Kuhn et al., 2013; Park et al., 2006); and E. coli BL21233
(DE3) is well established for recombinant gene expression and has been used for alkBGT and234
cv2025 co-expression enabling the proof of concept for the multistep conversion of DAME to235
ADAME (Schrewe et al., 2013b).236
237
Table 3: Specific ODAME transamination activities of E. coli strains containing AlaD and238
CV2025 with and without AlkL.239
Specific activities of E. coli strains [U gCDW−1]
Plasmids Ammonium sources BL21 (DE3) W3110 JM101
pAlaDTA none 0.40.1 0.40.1 0
50 mM Alanine 29.62.7 29.55.9 30.11.8
5 g/L NH4Cl 14.61.6 10.70.1 7.40.7
10 g/L NH4Cl 20.32.9 16.30.7 8.70.8
15 g/L NH4Cl 22.21.0 17.90.9 11.00.4
pAlaDTA,
pCom10alkL
none 0 0 0
50 mM Alanine 1988.0 2533.0 2107.3
5 g L−1 NH4Cl 10.20.4 17.60.2 9.10.5
10g L−1 NH4Cl 9.41.0 17.70.8 11.30.9
15 g L−1 NH4Cl 12.30.8 17.10.6 11.90.6
Bioconversions were performed with 0.8 − 1.35 gCDW L−1 of resting cells in Kpi buffer240
containing various ammonium sources and 2.5 mM ODAME. Specific activities are given in241
U gCDW−1 (1 U = 1 µmol min-1).242
243
As expected, ODAME was converted to ADAME at very low specific rates of 0 − 0.4 U gCDW−1244
in negative control reactions without ammonium source in the reaction buffer. Specific245
transamination rates between 7.4 and 22.2 U gCDW-1 were observed upon addition of 5 to 15246
g L−1 NH4Cl to the reaction buffer, indicating that the introduction of AlaD improved247
intracellular L-alanine availability in the absence of alanine in the medium.248
Recombinant E. coli BL21 (DE3) without AlkL showed the highest transamination activity249
with NH4Cl as ammonium source. A positive effect of the substrate uptake facilitator AlkL on250
the ODAME conversion rates was only observed upon alanine addition, where ADAME251
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formation rates increased by a factor of 6.6 – 8.5. With NH4Cl, AlkL did not significantly252
improve transamination rates in any of the strains. Apparently, the transaminase activity was253
limited by alanine supply via AlaD rather than ODAME availability.254
Facilitated substrate and intermediate uptake via AlkL can impair the biocatalyst stability due255
to toxification leading to a fast loss in energy (e.g., NADH)-dependent bioconversion activity256
(Julsing et al., 2012; Schrewe et al., 2014). With NH4Cl as N-source, E. coli BL21 (DE3)257
(pAlaDTA, pCom10alkL) showed lower transamination activities than E. coli BL21 (DE3)258
(pAlaDTA), while increased transamination rates were observed with L-alanine. The AlaD259
reaction is tightly linked to the cell’s carbon and energy metabolism via NADH, pyruvate, and260
the uptake of ammonium, whereas the transamination reaction only depends on ODAME and261
L-alanine availability. Thus, the higher CV2025-rates in presence of alanine can be explained262
by increased intracellular ODAME availability via AlkL. With NH4Cl, however, the energy263
metabolism-dependent AlaD reaction in the BL21 (DE3) strain and thus indirectly also the264
CV2025 reaction may have been compromised by toxic effects caused by facilitated ODAME265
transfer over the outer membrane mediated by AlkL. E. coli JM101 and E. coli W3110 showed266
similar transamination rates in the presence and absence of AlkL, obviously coping better with267
elevated intracellular ODAME concentrations.268
In comparison to the experiments performed with E. coli BL21 (DE3) (pTA) and L-alanine269
addition (Table 2), specific ODAME transamination rates (82 and 623 U gCDW-1 without and270
with AlkL, respectively) were between 2.8- and 3.1-fold lower with recombinant E. coli BL21271
(DE3) carrying the plasmid pAlaDTA (29.6 and 198 U gCDW-1, Table 3). This difference can be272
explained by lower CV2025 amounts formed in E. coli BL21 (DE3) (pAlaDTA) as compared273
to E. coli BL21 (DE3) (pTA) (see supplementary material, Fig. S4), in which the cv2025 gene274
is the first and not the second gene on the operon controlled by a stronger promoter system (T7275
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instead of lacUV5, see Table 1). The weaker lacUV5 promoter was chosen to enable efficient276
co-expression of multiple genes (see below).277
To conclude, the coupling of AlaD and CV2025 in vivo has been successfully achieved in all278
tested recombinant E. coli strains enabling efficient ODAME transamination independently of279
an external L-alanine feed. Furthermore, the experiments indicated that the investigated host280
organisms differ regarding their robustness towards an AlkL-mediated elevation of the substrate281
load.282
3.3 Multistep biotransformation of DAME in the presence of AlkL and AlaD283
As the next step, the combination of AlkL and AlaD was tested regarding its effect on the284
multistep conversion of DAME to ADAME. For this purpose, recombinant E. coli BL21 (DE3),285
E. coli W3110, and E. coli JM101 harboring the plasmids pAlaDTA and pBTL10 were286
employed in the presence of L-alanine or NH4Cl (Fig. 3).287
In the presence of L-alanine, the strains W3110 and JM101 showed similar maximum activities288
for all reaction steps with ADAME and DDAME as main products and similar product yields289
on biomass after 60 min. E. coli BL21 (DE3) showed lower activities and yields and a higher290
HDAME product share. As observed for ODAME conversion (Table 3), lower transamination291
rates were obtained when NH4Cl was used as ammonium source. Increasing the ammonium292
concentration did not result in increased maximum ADAME formation rates and yields with293
the BL21 (DE3) strain, which, in contrast, was the case with E. coli W3110 and especially E.294
coli JM101 (Fig. 3B). With the latter two strains, the intracellular alanine supply via AlaD again295
appeared to limit amine formation and directly influenced the product formation pattern.296
Increasing ammonium concentrations resulted in increasing amine to acid ratios.297
298
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299
Fig. 3: Maximum specific activities (U gCDW−1) (A) and product yields on biomass300
(mmol gCDW−1) (B) obtained in bioconversions of 2.5 mM DAME performed for 60 min with301
E. coli strains BL21 (DE3), W3110, and JM101 containing pAlaDTA and pBTL10. The same302
procedure as for the experiment shown in Fig. 2 was followed and maximum activities given303
in panel A refer to the time intervals with the highest respective activities. Cell concentration304
applied: 0.63 - 1.0 gCDW L−1. Kpi buffer was supplemented with 50 mM L-alanine or 5, 10, or305
15 g L-1 NH4Cl. Detected amounts of the hydrolysis products (i.e., 12-hydroxydodecanoic acid,306
dodecanedioic acid, and 12-aminododecanoic acid) were summed up with those of307
corresponding esters. Reaction step nomenclature and abbreviations are as given in the legend308
of Fig. 1.309
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In contrast to their higher oxygenation and transamination activities and product yields on310
biomass, E. coli W3110 and E. coli JM101 synthesized AlkB and CV2025 to slightly lower311
levels as compared to E. coli BL21 (DE3) (see supplementary material Figs. S4, S5, S6). Thus,312
either not all enzymes formed were active or, as already inferred from the reduced AlaD-limited313
transamination rates in the presence of AlkL in E. coli BL21 (DE3) (Table 3), toxic314
substrate/product levels compromised cell metabolism and thus pyruvate supply, NADH315
regeneration, and/or ammonium uptake to a greater extent in E. coli BL21 (DE3). Since E. coli316
JM101 performed slightly better than E. coli W3110 with NH4Cl as ammonium source and the317
latter strain showed drastically reduced growth after transformation with both plasmids (for318
further information see supplementary material, Table S1), E. coli JM101 was chosen as the319
most suitable host strain.320
3.4 The alcohol dehydrogenase AlkJ facilitates ADAME synthesis321
ODAME transamination by cells with and without AlkL in the outer membrane revealed a322
direct dependence of respective activities on intracellular ODAME availability (Table 3). The323
multistep conversion of DAME involving AlkL, AlkBGT, and CV2025 resulted in the parallel324
accumulation of DDAME and ADAME, whereas only very low amounts of ODAME were325
detected pointing to ODAME limitation (Figs. 2 and 4A). To support ODAME formation, the326
heterologous pathway was amended by the NAD(P)H independent alcohol dehydrogenase AlkJ327
from P. putida GPo1. AlkJ transfers electrons to the electron transport chain (Kirmair and328
Skerra, 2014) and thus catalyzes irreversible alcohol oxidation (Schrewe et al., 2014).329
Whereas the bioconversion of DAME with E. coli JM101 (pAlaDTA, pBTL10) resulted in330
similar specific DDAME and ADAME formation rates and yields (Fig. 4A and B), the331
introduction of AlkJ effected a clear shift towards the desired amine formation (Fig. 4C and D).332
This effect involved increased ODAME (Step 2) and ADAME (Step TA) formation rates and333
slightly decreased DDAME (Step 3) formation rates.334
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Fig. 4: DAME bioconversion with E. coli JM101 (pAlaDTA, pBTL10) (0.64 gCDW L−1; A and336
B) and E. coli JM101 (pAlaDTA, pBTJL10) (0.93 gCDW L−1; C and D). The course of substrate,337
intermediate, and product concentrations (A and C) and of specific activities (B and D) is given.338
Kpi buffer was supplemented with 15 g L−1 NH4Cl. The concentrations of hydrolysis products339
(i.e., 12-hydroxydodecanoic acid, dodecanedioic acid, and 12-aminododecanic acid) were340
summed up with those of the corresponding esters. See supplementary material, Figs. S2 and341
S3 about details on ester hydrolysis. Reaction step nomenclature and abbreviations are as given342
in the legend of Fig. 1.343
344
The increase of the fluxes through the orthogonal ADAME synthesis pathway as it was345
achieved via the introduction of AlkL and AlkJ and the establishment of intracellular alanine346
supply via AlaD now enables the production of ADAME as main product without external347
alanine feeding. The metabolically engineered recombinant strain E. coli JM101 (pAlaDTA,348
pBTL10) represents an excellent basis for the establishment of a process for Nylon 12349
production from renewable DAME.350
351
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4. Discussion352
4.1 The role of hydrophobic substrate uptake in ADAME synthesis353
Whole-cell catalyzed ADAME synthesis from plant oil derived DAME suffers from substrate354
uptake limitation over the cellular membranes (Schrewe et al., 2013b). The hydrophilic355
lipopolysaccharide layer on the surface of microbial cells and the hydrophilic nature of typical356
outer membrane pores constitute a barrier for larger, hydrophobic compounds, whereas the357
cytoplasmic membrane represents a barrier for hydrophilic molecules (Chen, 2007; Leive,358
1974; Nikaido, 2003). Substrate uptake into microbial cells can be enhanced via the359
introduction of transport proteins or pores into cellular membranes. As reported recently, the360
outer membrane protein AlkL from P. putida GPo1 has been proven to enable efficient transfer361
of alkanes, fatty acids, fatty acid methyl esters, and terpenes over the outer cell membrane,362
boosting the hydroxylation activity of recombinant E. coli towards such hydrophobic or363
amphiphilic compounds (Cornelissen et al., 2013; Julsing et al., 2012; Scheps et al., 2013). In364
the present work, the incorporation of AlkL into the investigated E. coli strains resulted in365
increased specific rates for ODAME transamination and for the flux through the orthogonal366
pathway from DAME to ADAME. However, boosted uptake via AlkL has been observed to367
cause/intensify substrate/product toxicity (Julsing et al., 2012; Schrewe et al., 2014). Similarly,368
using E. coli BL21 (DE3) as host strain, high AlkL levels appeared to hamper AlaD-driven369
ODAME transamination and orthogonal pathway performance (Table 3, Fig. 3).370
Substrate/product toxicity might become a critical issue for process development and scale up371
involving higher substrate and product concentrations. Typically, substrate and product372
toxification can be prevented by regulated substrate addition and in situ product removal, e.g.,373
via evaporation, extraction, permeation, immobilization, or precipitation (Stark and von374
Stockar, 2003).375
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4.2 AlaD – linking central carbon metabolism and the orthogonal pathway enabled376
intracellular L-alanine supply for efficient transamination377
E. coli is able to produce L-alanine intracellularly. On average, E. coli produces L-alanine at378
rates of around 0.73 mmol gCDW−1 h−1 (12.2 U gCDW−1) during exponential growth at 37 °C in379
glucose containing minimal medium (Pramanik and Keasling, 1997). However, such native L-380
alanine synthesis was not sufficient to efficiently support ODAME transamination resulting in381
only poor ADAME formation from DAME with resting E. coli BL21 (DE3) (pTA, pBTL10)382
(Schrewe et al., 2013b). Connecting the orthogonal pathway to the central carbon metabolism383
via the B. subtilis alanine dehydrogenase AlaD to enhance L-alanine formation from pyruvate384
enabled efficient transamination in alanine-free medium. However, with ODAME as well as385
DAME as substrate, alanine supply via AlaD still limited the transamination reaction, as it can386
be deduced from the higher rates achieved when L-alanine was provided externally. AlaD-387
catalysis strictly depends on the availability of ammonium. Accordingly, the ammonium388
concentration in the reaction medium was found to be critical regarding orthogonal pathway389
performance. Similarly, L-alanine production in E. coli involving B. sphaericus AlaD was390
reported to cease at low ammonium concentrations and could be sustained by pulsing 15 g L−1391
NH4Cl (Lee et al., 2004). For B. subtilis AlaD, a high Michaelis-Menten constant towards NH4+392
has been reported (KM = 38 mM, determined in vitro at 25 °C and pH 8; Yoshida and Freese,393
1965). This, in combination with the intracellular competition for NH4+, e.g., with glutamate394
dehydrogenase, can be considered critical for efficient in vivo transamination necessitating a395
tight control of ammonium levels in the medium or making AlaD a target for respective protein396
engineering.397
Next to NH4+, AlaD-catalysis also interferes with the intracellular pyruvate pool. In principle,398
one molecule of pyruvate is released upon ODAME amination and can be recycled to L-alanine399
via AlaD. However, pyruvate is a key metabolite of the central carbon metabolism, for which400
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several host intrinsic enzyme reactions are competing. Thus, further strain engineering, i.e., the401
knockout or knockdown of competing pyruvate consuming reactions, may improve AlaD- and402
transaminase catalysis. Such a strategy has been followed for alanine production by E. coli403
overproducing recombinant AlaD. The knockout of pyruvate-formatelyase, pyruvate oxidase,404
phosphoenolpyruvate synthase, lactate dehydrogenase, as well as components of the pyruvate405
dehydrogenase complex resulted in the production of up to 88 g L−1 D-/L-alanine from glucose406
in a fed-batch-based bioprocess (Smith et al., 2006). However, TCA cycle activity and407
NAD(P)H formation are expected to be impaired in pyruvate dehydrogenase deficient strains.408
As NADH is the source of reduction equivalents for both AlkB and AlaD, a knockout or409
knockdown of genes with a key role in the central carbon metabolism and especially in410
NAD(P)H regeneration needs careful evaluation. Hence, a quantitative metabolome and flux411
analysis under biotransformation conditions may be of interest to evaluate pyruvate node412
operation.413
The pH dependency of AlaD operation may also be a promising engineering target. In vitro414
studies on AlaD revealed an optimum pH of 9 and alanine formation rates were reduced to 20%415
at pH 7.2 (Yoshida and Freese, 1965). Over an external pH range of 5 – 9, E. coli maintains its416
cytoplasmic pH between 7.4 and 7.8, when optimal growth conditions are applied (Slonczewski417
et al., 1981; Wilks and Slonczewski, 2007; Zilberstein et al., 1984). Thus, the full potential of418
AlaD was not exploited for ADAME formation. An AlaD homologue with a pH optimum at419
neutral pH such as AlaD from Mycobacterium tuberculosis (Hutter and Singh, 1999) may be420
used or protein engineering approaches may be chosen to further improve alanine synthesis and421
thus ADAME production with engineered E. coli.422
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4.3 Choice of host organism423
In general, robustness of microbial cells towards toxic substrates and products as well as the424
applied process conditions is crucial for commercial process applications in industry (Keasling,425
2012; Schmid et al., 2001; Schrewe et al., 2013a). Among the E. coli strains tested, E. coli BL21426
(DE3) carrying AlaD and CV2025 showed the best transamination performance with NH4Cl as427
ammonium source, but only in the absence of AlkL and/or AlkBGT. Facilitated uptake via AlkL428
may cause toxification by substrate and/or products and thus affect cell metabolism and429
NAD(P)H regeneration compromising AlkBGT and AlaD activity. E. coli W3110 and E. coli430
JM101 outperformed E. coli BL21 (DE3) in terms of ADAME synthesis from DAME. This is431
in agreement with the higher robustness of W3110 and especially JM101 towards solvents as it432
has been shown for styrene oxide (Park et al., 2006). Without induction, the introduction of433
pAlaDTA and pBTL10 into W3110 and JM101 resulted in a reduction of the exponential434
growth rate by 70% and 30%, respectively, whereas this effect was not observed for BL21435
(DE3) (see supplementary material, Table S1). Growth of all tested strains was further impaired436
after induction of gene expression, resulting in maximum growth rates of 0.16 and 0.15 h−1 for437
E. coli BL21 (DE3) and E. coli JM101, respectively, and even in linear growth for E. coli438
W3110. The latter strain obviously was most affected by recombinant gene expression. Thus,439
among the strains evaluated in this study, E. coli JM101 can be considered the strain of choice440
with regard to robustness towards both organic solvents (substrate/products) and recombinant441
gene expression.442
This study clearly demonstrates that careful host evaluation and selection are essential for443
efficient bioprocessing based on orthogonal pathways, which typically are highly444
interconnected with cell functionalities such as carbon and energy metabolism, gene expression,445
substrate uptake, and robustness towards organic compounds.446
447
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4.4 Shift of product formation pattern towards ADAME accumulation448
Similar to the xylene monooxygenase of P. putida mt-2 (Bühler et al., 2000), AlkBGT does not449
only catalyze terminal hydroxylation but also the further oxidation of resulting alcohols to450
corresponding aldehydes and acids (Schrewe et al., 2013b). Regarding the coupling of451
AlkBGT- and CV2025-catalysis to produce ADAME, ODAME overoxidation constitutes a452
competing reaction. ODAME accumulated only to low amounts (Fig. 4 A) and its availability,453
beside that of alanine, obviously limited the transamination reaction during ADAME synthesis454
from DAME with E. coli JM101 (pAlaDTA, pBTL10). Hence, the synthetic pathway was455
amended by the P. putida GPo1 alcohol dehydrogenase AlkJ which is linked to the electron456
transport chain and thus catalyzes an irreversible alcohol oxidation in vivo (Kirmair and Skerra,457
2014; Schrewe et al., 2014). The introduction of AlkJ was found not only to promote HDAME458
oxidation but also to favor ADAME over DDAME formation (Fig. 4). Obviously, AlkJ459
increased the intracellular availability of ODAME fostering CV2025- but not AlkBGT460
catalysis. This may be due to enzyme kinetics and/or reaction thermodynamics.461
Regarding ODAME conversion kinetics, the predominance of CV2025 over AlkBGT catalysis462
as a consequence of the AlkJ-mediated increase in ODAME supply and levels (extracellular463
concentrations: 0.016 mM without and 0.028 mM with AlkJ, Fig. 4) indicates that both Vmax464
and KM of CV2025 are higher than those of AlkBGT. Indeed, maximal ODAME conversion465
activities and ODAME uptake constants (KS values) of AlkL-containing cells in the presence466
of alanine were clearly higher for CV2025 (623 U gCDW-1, Table 2; subject of substrate467
inhibition: Vmax = 3150 ± 1020 U gCDW-1, KS = 3.2 ± 1.2 mM, , Ki = 1.0 ± 0.4 mM, unpublished468
data) as comparted to AlkBGT (Vmax = 103 ± 11 U gCDW-1, KS = 0.19 ± 0.06 mM, Schrewe et469
al., 2014). It has to be considered that substrate uptake constants may be dominated by AlkL470
kinetics and that intracellular enzyme affinities are difficult to judge, especially for membrane471
bound enzymes such as AlkB, which, however, profits from the high solubility of ODAME in472
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and its partitioning into membranes. Overall, these kinetic considerations are in agreement with473
the observed preference for ODAME oxidation and ODAME transamination at low and high474
ODAME availabilities, respectively.475
The thermodynamics of reversible transamination with an equilibrium constant Keq of 134, as476
estimated via the group contribution method of Mavrovouniotis (1991), may also play a crucial477
role considering the low ODAME levels in the reaction broth. Accordingly, higher intracellular478
ODAME concentrations reached in presence of AlkJ can be expected to increase the net479
ADAME formation rate, whereas irreversible ODAME oxidation by AlkBGT is not influenced480
by an active back reaction and may already have run at close to maximal speed in the absence481
of AlkJ. Moreover, ADAME synthesis may become favored over direct further oxidation of482
ODAME by AlkBGT, if AlkJ rather than AlkBGT (no dissociation of ODAME necessary in483
this case) catalyzes ODAME formation. However, the favored ADAME formation achieved484
via the introduction of AlkJ augurs well for the development of a bioprocess featuring485
predominant ADAME production with renewable DAME as substrate.486
Future work will focus on the application of reaction engineering approaches in order to487
synthesize ADAME on a larger scale. In this respect, the two-liquid phase bioreactor concept488
represents a good strategy to exploit reaction kinetics and to further increase the product yield489
(Bühler et al., 2003; Lye and Woodley, 1999; Schrewe et al., 2014).490
491
5. Conclusions492
This study reports on the design and engineering of a completely heterologous, rationally493
compiled pathway involving oxygenase, dehydrogenase, and transaminase catalysis for the494
production of ADAME, a valuable monomer for Nylon 12 synthesis. To overcome the major495
limitations for the synthesis ADAME from renewable DAME, strain and pathway engineering496
targeted hydrophobic substrate uptake, intracellular alanine supply to support transaminase497
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catalysis, and the introduction of an additional alcohol oxidizing activity to improve pathway498
flux. Via these strategies, both the specific ADAME formation rate and the yield on biomass499
were increased 10- and 3.5-fold, respectively. Careful host evaluation and selection as well as500
the consideration and engineering of general functionalities of microbial cells proved to be501
crucial to improve the performance of the heterologous pathway. Such cascade biocatalysis502
based on orthogonal pathway design and engineering constitutes a novel strategy, which503
enlarges the substrate scope of metabolically engineered microorganisms and finally sets the504
basis to produce Nylon 12 consisting of 100% renewable carbon.505
506
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I. DNA and amino acid sequence of B. subtilis alaD on plasmid pAlaDTA696
DNA sequence:697
ATGATCATAGGGGTTCCTAAAGAGATAAAAAACAATGAAAACCGTGTCGCATTAACACC698
CGGGGGCGTTTCTCAGCTCATTTCAAACGGCCACCGGGTGCTGGTTGAAACAGGCGCGGG699
CCTTGGAAGCGGATTTGAAAATGAAGCCTATGAGTCAGCAGGAGCGGAAATCATTGCTG700
ATCCGAAGCAGGTCTGGGACGCCGAAATGGTCATGAAAGTAAAAGAACCGCTGCCGGAA701
GAATATGTTTATTTTCGCAAAGGACTTGTGCTGTTTACGTACCTTCATTTAGCAGCTGAGC702
CTGAGCTTGCACAGGCCTTGAAGGATAAAGGAGTAACTGCCATCGCATATGAAACGGTC703
AGTGAAGGCCGGACATTGCCTCTTCTGACGCCAATGTCAGAGGTTGCGGGCAGAATGGCA704
GCGCAAATCGGCGCTCAATTCTTAGAAAAGCCTAAAGGCGGAAAAGGCATTCTGCTTGCC705
GGGGTGCCTGGCGTTTCCCGCGGAAAAGTAACAATTATCGGAGGAGGCGTTGTCGGGAC706
AAACGCGGCGAAAATGGCTGTCGGCCTCGGTGCAGATGTGACGATCATTGACTTAAACGC707
AGACCGCTTGCGCCAGCTTGATGACATCTTCGGCCATCAGATTAAAACGTTAATTTCTAAT708
CCGGTCAATATTGCTGATGCTGTGGCGGAAGCGGATCTCCTCATTTGCGCGGTATTAATTC709
CGGGTGCTAAAGCTCCGACTCTTGTCACTGAGGAAATGGTAAAACAAATGAAACCCGGTT710
CAGTTATTGTTGATGTAGCGATCGACCAAGGCGGCATCGTCGAAACTGTCGACCATATCA711
CAACACATGATCAGCCAACATATGAAAAACACGGGGTTGTGCATTATGCTGTAGCGAAC712
ATGCCAGGCGCAGTCCCTCGTACATCAACAATCGCCCTGACTAACGTTACTGTTCCATAC713
GCGCTGCAAATCGCGAACAAAGGGGCAGTAAAAGCGCTCGCAGACAATACGGCACTGAG714
AGCGGGTTTAAACACCGCAAACGGACACGTGACCTATGAAGCTGTAGCAAGAGATCTAG715
GCTATGAGTATGTTCCTGCCGAGAAAGCTTTACAGGATGAATCATCTGTGGCGGGTGCTT716
AA717
718
Amino acid sequence:719
MIIGVPKEIKNNENRVALTPGGVSQLISNGHRVLVETGAGLGSGFENEAYESAGAEIIADPKQV720
WDAEMVMKVKEPLPEEYVYFRKGLVLFTYLHLAAEPELAQALKDKGVTAIAYETVSEGRTL721
PLLTPMSEVAGRMAAQIGAQFLEKPKGGKGILLAGVPGVSRGKVTIIGGGVVGTNAAKMAV722
GLGADVTIIDLNADRLRQLDDIFGHQIKTLISNPVNIADAVAEADLLICAVLIPGAKAPTLVTEE723
MVKQMKPGSVIVDVAIDQGGIVETVDHITTHDQPTYEKHGVVHYAVANMPGAVPRTSTIALT724
NVTVPYALQIANKGAVKALADNTALRAGLNTANGHVTYEAVARDLGYEYVPAEKALQDES725
SVAGA726
727
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II. DNA and amino acid sequence of codon optimized cv2025 -TA from C. violaceum on728
pAlaDTA729
730
DNA sequence:731
ATGCAGAAACAGCGTACCACCTCTCAGTGGCGTGAACTCGATGCGGCGCATCATCTCCAT732
CCGTTTACCGATACCGCGAGCCTCAATCAGGCGGGTGCGCGTGTGATGACCCGTGGCGAA733
GGCGTGTATCTCTGGGATAGCGAAGGCAACAAAATTATTGATGGCATGGCGGGCCTCTGG734
TGCGTGAACGTGGGCTATGGCCGTAAAGATTTTGCGGAAGCGGCGCGTCGTCAGATGGA735
AGAACTCCCGTTTTATAACACCTTCTTTAAAACCACCCATCCGGCGGTGGTGGAACTCAG736
CAGCCTCCTCGCCGAAGTTACCCCGGCAGGTTTTGATCGTGTGTTTTATACCAACAGCGGC737
AGCGAAAGCGTGGATACCATGATTCGTATGGTGCGTCGTTATTGGGATGTGCAGGGCAAA738
CCGGAAAAAAAAACCCTCATTGGCCGTTGGAACGGCTATCACGGCAGCACCATTGGCGG739
TGCGAGCCTCGGCGGCATGAAATATATGCATGAACAGGGCGATCTCCCGATTCCGGGCAT740
GGCGCATATTGAACAGCCGTGGTGGTATAAACATGGCAAAGATATGACCCCGGATGAAT741
TTGGCGTGGTTGCGGCGCGTTGGCTCGAAGAAAAAATTCTCGAAATCGGCGCGGATAAA742
GTGGCGGCGTTTGTGGGCGAACCGATTCAGGGTGCGGGCGGTGTGATTGTTCCGCCGGCA743
ACCTATTGGCCGGAAATTGAACGTATTTGCCGCAAATATGATGTGCTCCTCGTTGCGGAT744
GAAGTGATTTGCGGCTTTGGCCGTACCGGCGAATGGTTTGGCCATCAGCATTTTGGCTTTC745
AGCCGGACCTCTTTACCGCGGCGAAAGGCCTCAGCAGCGGCTATCTCCCGATTGGCGCGG746
TGTTTGTGGGCAAACGTGTTGCGGAAGGTCTCATTGCGGGCGGTGATTTTAACCATGGCT747
TTACCTATAGCGGCCATCCGGTGTGTGCGGCGGTGGCGCATGCGAATGTTGCGGCGCTCC748
GTGATGAAGGCATTGTGCAGCGTGTGAAAGATGATATTGGCCCGTATATGCAGAAACGTT749
GGCGTGAAACCTTTAGCCGTTTTGAACATGTGGATGATGTGCGTGGCGTGGGCATGGTGC750
AGGCGTTTACCCTCGTGAAAAACAAAGCGAAACGTGAACTCTTTCCGGATTTTGGCGAAA751
TTGGCACCCTCTGCCGCGATATTTTTTTTCGCAACAACCTCATTATGCGTGCGTGCGGCGA752
TCACATTGTGTCTGCACCGCCGCTCGTTATGACCCGTGCGGAAGTGGATGAAATGCTCGC753
CGTGGCGGAACGTTGCCTCGAAGAATTTGAACAGACCCTCAAAGCGCGTGGCCTCGCCTA754
A755
756
757
Amino acid sequence:758
MQKQRTTSQWRELDAAHHLHPFTDTASLNQAGARVMTRGEGVYLWDSEGNKIIDGMAGLW759
CVNVGYGRKDFAEAARRQMEELPFYNTFFKTTHPAVVELSSLLAEVTPAGFDRVFYTNSGSE760
SVDTMIRMVRRYWDVQGKPEKKTLIGRWNGYHGSTIGGASLGGMKYMHEQGDLPIPGMAH761
IEQPWWYKHGKDMTPDEFGVVAARWLEEKILEIGADKVAAFVGEPIQGAGGVIVPPATYWP762
EIERICRKYDVLLVADEVICGFGRTGEWFGHQHFGFQPDLFTAAKGLSSGYLPIGAVFVGKRV763
AEGLIAGGDFNHGFTYSGHPVCAAVAHANVAALRDEGIVQRVKDDIGPYMQKRWRETFSRF764
EHVDDVRGVGMVQAFTLVKNKAKRELFPDFGEIGTLCRDIFFRNNLIMRACGDHIVSAPPLV765
MTRAEVDEMLAVAERCLEEFEQTLKARGLA766
767
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III. Supplementary table768
769
The growth behavior of recombinant E. coli carrying either the plasmid pAlaDTA or the770
plasmids pAlaDTA/pBTL10 was investigated in M9* minimal medium at 30°C. Induction was771
carried out with 1mM IPTG for strains carrying pAlaDTA or with 0.025% when pBTL10 was772
present in the cells.773
774
Table S1 Maximum growth rates (µmax [h-1]) of recombinant E. coli strains carrying pAlaDTA775
or pAlaDTA in combination with pBTL10.776
w/o plasmid pAlaDTA pAlaDTA/pBTL10
µmax [h-1] uninduced induceda) uninduced inducedb)
BL21 (DE3) 0.380.05 0.350.04 0.350.05 0.390.05 0.160.05
W3110 0.550.08 0.330.05 0.280.06 0.160.03 linear
JM101 0.470.09 0.400.06 0.380.05 0.330.04 0.150.03
Induction was performed after growing the cells to a concentration of 0.083 gCDW L-1.777
a) induction with 1 mM IPTG778
b) induction with 1mM IPTG and 0.025% DCPK779
780
781
782
783
34
IV. Supplementary figures784
785
786
Fig. S1: Hydrolyzed and non-hydrolyzed alcohol, aldehyde (not detected), acid, and amine787
products accumulating during the whole-cell biotransformation of DAME shown in Fig. 2 with788
E. coli BL21 (DE3) (pTA, pBTL10). Cell concentration applied: 1.25 gCDW L-1. Kpi buffer was789
supplemented with 50 mM L-alanine. HDAME, 12-hydroxydodecanoic acid methyl ester;790
ODAME, 12-oxododecanoic acid methyl ester; DDAME, dodecanedioic acid monomethyl791
ester; ADAME, 12-aminododecanoic acid methyl ester; HAD, 12-hydroxydodecanoic acid;792
DDA, dodecanedioic acid; ADA, 12-aminododecanoic acid.793
794
795
796
797
Fig. S2: Hydrolyzed and non-hydrolyzed alcohol, aldehyde (not detected), acid, and amine798
products accumulated during the whole-cell biotransformation of DAME shown in Fig. 4AB799
with E. coli JM101 (pAlaDTA, pBTL10). Cell concentration applied: 0.64 gCDW L-1. Kpi buffer800
was supplemented with 15 g L-1 NH4Cl. Abbreviations are as given in the legend of Fig. S1.801
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802
803
804
Fig. S3: Hydrolyzed and non-hydrolyzed alcohol, aldehyde (not detected), acid and amine805
products accumulated during the whole-cell biotransformation of DAME shown in Fig 4CD806
with E. coli JM101 (pAlaDTA, pBTJL10). Cell concentration applied: 0.64 gCDW L-1. Kpi buffer807
was supplemented with 15 g L-1 NH4Cl. Abbreviations are as given in the legend of Fig. S1.808
809
810
Fig. S4: SDS-PAGE analysis of recombinant E. coli BL21 (DE3) carrying different plasmids.811
pTA in lanes 1 and 2, pTA and pBTL10 in lanes 3 and 4, pTA and pCom10alkL in lanes 5 and812
6, pAlaDTA in lanes 7 and 8, and pAlaDTA and pBTL10 in lanes 9 and10. Lane M, PageRuler813
SM26614 (Fermentas GmbH, St. Leon-Rot, Germany). “-“ = uninduced cultures, “+” = after 5814
h of induction. Induction was carried out with 1 mM IPTG for strains carrying the plasmids815
pTA or pAlaDTA and with 0.025% (v/v) DCPK for strains harboring pBTL10. Approx.15 µg816
of total cell dry weight was loaded. Expected molecular mass: CV2025:  47 kDa (Kaulmann817
et al., 2007), AlaD:  42 kDa (Ye et al., 2010); AlkB:  41 kDa (Schrewe et al., 2011).818
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819
820
Fig. S5: SDS-PAGE analysis of recombinant E. coli W3110 carrying different plasmids.821
pAlaDTA in lanes 1 and 2, pAlaDTA and pBTL10 in lanes 3 and 4. Lane M, PageRuler822
SM26614 (Fermentas GmbH, St. Leon-Rot, Germany). “-“ = uninduced cultures, “+” = after 5823
h of induction. Induction was carried out with 1 mM IPTG for strains carrying the plasmid824
pAlaDTA and with 0.025% (v/v) DCPK for strains harboring pBTL10. Approx.15 µg of total825
cell dry weight was loaded. Expected molecular mass: CV2025:  47 kDa (Kaulmann et al.,826
2007), AlaD:  42 kDa (Ye et al., 2010); AlkB:  41 kDa (Schrewe et al., 2011).827
828
829
830
831
Fig. S6: SDS-PAGE analysis of recombinant E. coli JM101 carrying different plasmids.832
pAlaDTA in lanes 1 and 2, pAlaDTA and pBTL10 in lanes 3 and 4. M: PageRuler SM26614833
(Fermentas GmbH, St. Leon-Rot, Germany). “-“ = uninduced cultures, “+” = after 5 h of834
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induction. Induction was carried out with 1 mM IPTG for strains carrying the plasmid pAlaDTA835
and with 0.025% (v/v) DCPK for strains harboring pBTL10. Approx.15 µg of total cell dry836
weight was loaded. Expected molecular mass: CV2025:  47 kDa (Kaulmann et al., 2007),837
AlaD:  42 kDa (Ye et al., 2010); AlkB:  41 kDa (Schrewe et al., 2011).838
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